These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack. Le CT, Hollaar L, van der Valk EJ, van der Laarse A. J Mol Cell Cardiol; 1993 May; 25(5):519-28. PubMed ID: 8104252 [Abstract] [Full Text] [Related]
6. Depletion of glutathione by L-buthionine sulfoximine does not promote inactivation of myo-inositol transport in cultured bovine lens epithelial cells. Cammarata PR, Tse D, Yorio T. Curr Eye Res; 1991 Apr; 10(4):321-30. PubMed ID: 1676962 [Abstract] [Full Text] [Related]
7. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro. Shrieve DC, Denekamp J, Minchinton AI. Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545 [Abstract] [Full Text] [Related]
8. Left ventricular function during chronic endotoxemia in swine. Lee K, van der Zee H, Dziuban SW, Luhmann K, Goldfarb RD. Am J Physiol; 1988 Feb; 254(2 Pt 2):H324-30. PubMed ID: 3344822 [Abstract] [Full Text] [Related]
10. Variation in end-systolic pressure-diameter relationship using dP/dtmin or P/Dmax as a definition of end-systole in chronic endotoxemic pigs. Goldfarb RD, Lee KJ, Dziuban SW. Circ Shock; 1989 Jun; 28(2):109-19. PubMed ID: 2736726 [Abstract] [Full Text] [Related]
13. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio. Mitchell JB, Russo A, Biaglow JE, McPherson S. Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769 [Abstract] [Full Text] [Related]
15. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow. Ono K, Shrieve DC. J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662 [Abstract] [Full Text] [Related]
16. The pulmonary effects of buthionine sulfoximine treatment and glutathione depletion in rats. Coursin DB, Cihla HP. Am Rev Respir Dis; 1988 Dec; 138(6):1471-9. PubMed ID: 3202501 [Abstract] [Full Text] [Related]
17. Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine. Malaker K, Hurwitz SJ, Bump EA, Griffith OW, Lai LL, Riese N, Coleman CN. Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):407-12. PubMed ID: 7910818 [Abstract] [Full Text] [Related]
18. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine. Sun JD, Ragsdale SS, Benson JM, Henderson RF. Fundam Appl Toxicol; 1985 Oct 15; 5(5):913-9. PubMed ID: 2866140 [Abstract] [Full Text] [Related]
19. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation. Standeven AM, Wetterhahn KE. Toxicol Appl Pharmacol; 1991 Feb 15; 107(2):269-84. PubMed ID: 1994510 [Abstract] [Full Text] [Related]
20. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines. Mistry P, Loh SY, Kelland LR, Harrap KR. Int J Cancer; 1993 Nov 11; 55(5):848-56. PubMed ID: 8244583 [Abstract] [Full Text] [Related] Page: [Next] [New Search]